Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Enterprise value

Enterprise value at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
Cardinal Health logo
Cardinal HealthCAH
$54.7B+45.4%
Medline, Inc. logo
Medline, Inc. MDLN
$46.44B—
Viatris logo
ViatrisVTRS
$28.36B+17.7%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$21.15B-42.9%
Amcor logo
AmcorAMCR
$32.92B+55.2%

Other financials

Income statement

See full
Revenue$844.9M+21.1%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$22.86B+11.6%
P/E42.1×-1.7×
P/S7.1×0.0×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Calculated from West Pharmaceutical Services’s reported figures.

$18.1Bmarket cap+$321.0Mtotal debt−$521.4Mcash and equivalents=$17.87B

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's enterprise value?
West Pharmaceutical Services (WST) reported enterprise value of $17.87B in Q1 2026.
How has West Pharmaceutical Services's enterprise value changed year-over-year?
West Pharmaceutical Services's enterprise value increased by 11.1% year-over-year, from $16.09B to $17.87B.
What is the long-term trend for West Pharmaceutical Services's enterprise value?
Over 4 years (2021 to 2025), West Pharmaceutical Services's enterprise value has grown at a -11.3% compound annual growth rate (CAGR), from $112.44B to $69.75B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.